Distribution of p53 alterations in a case of gliomatosis cerebri

Human Pathology

Volumn 34, Issue 1, 2003, Pages 102-106

  Mawrin, Christian ^a   Lins, Hartmut ^a   Kirches, Elmar ^a   Schildhaus, Hans Ulrich ^a   Scherlach, Cordula ^a   Kanakis, Dimitrios ^a   Dietzman, Knut ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Gliomatosis cerebri; Magnetic resonance imaging; p53

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; BASAL GANGLION; CASE REPORT; CLINICAL FEATURE; COGNITION; DISEASE COURSE; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; GLIOMATOSIS CEREBRI; HEMISPHERE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEUROEPITHELIOMA; TUMOR SUPPRESSOR GENE;

EID: 0037259036     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2003.1     Document Type: Article

References (16)

1. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 88:323-331, 1997
2. Watanabe K, Sato K, Biernat W, et al: Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies. Clin Cancer Res 3:523-530, 1997
3. Ohgaki H, Eibl RH, Wiestler OD, et al: p53 mutations in nonastrocytic human brain tumors. Cancer Res 51:6202-6205, 1991
4. Jennings MT, Frenchman M, Shehab T, et al: Gliomatosis cerebri presenting as intractable epilepsy during early childhood. J Child Neurol 10:37-45, 1995
5. Mawrin C, Aumann V, Kirches E, et al: Gliomatosis cerebri: Postmortem molecular and immunohistochemical analyses in a case treated with thalidomide. J Neurooncol 55:11-17, 2001
6. Kim DG, Yang HJ, Park IA, et al: Gliomatosis cerebri: Clinical features, treatment, and prognosis. Acta Neurochirurg 140:755-762, 1998
7. Freund M, Hahnel S, Sommer C, et al: CT and NRI findings in gliomatosis cerebri: A neuroradiologic and neuropathologic review of diffuse infiltrating brain neoplasms. Eur Radiol 11:309-316, 2001
8. Kleihues P, Burger PC, Scheithauer BW: The new WHO classification of brain tumors. Brain Pathol 3:255-268, 1993
9. Kleihues P, Ohgaki H: Primary and secondary glioblastomas: From concept to clinical diagnosis. Neuro-oncology 1:44-51, 1999
10. Ohgaki H, Watanabe K, Peraud A, et al: A case history of glioma progression. Acta Neuropathol 97:525-532, 1999
11. Malkin D, Li FP, Strong LC, et al: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233-1238, 1990
12. Louis DN, von Deimling A, Chung RY, et al: Comparative study of p53 gene and protein alterations in human astrocytic tumors. J Neuropathol Exp Neurol 52:31-38, 1993
13. Taylor D, Koch WM, Zahurak, M, et al: Immunohistochemical detection of p53 protein accumulation in head and neck cancers: Correlation with p53 gene alterations. HUM PATHOL 30:1221-1225
14. Artigas J, Cervos-Navarro J, Iglesias JR, et al: Gliomatosis cerebri: Clinical and histological findings. Clin Neuropathol 4:135-148, 1985
15. Hecht BK, Turc-Carel C, Chatel M, et al: Chromosomes in gliomatosis cerebri. Genes Chromosomes Cancer 14:149-153, 1995
16. Kattar MM, Kupsky WJ, Shimoyama RK, et al: Clonal analysis of gliomas. HUM PATHOL 28:1166-1179, 1997